BrightKaire Goes Beyond Genetic Testing
Pharmacogenetic (PGx) tests show how your body processes a medication.
BrightKaire measures your biology — how your brain responds to it — a fundamentally different
signal for treatment decisions.
BrightKaire vs PGx Testing vs No Testing
Dimension
No Testing
PGx Testing
BrightKaire
What’s measured
--
Drug metabolism &tolerance
Neurobiological response
Signal type
--
Indirect proxy
Direct functional response
Data type
--
Static genetic markers
Dynamic cellular behavior
Primary value
Trial-and-error
Avoid side effects
Increase likelihood ofresponse
Clinical question answered
--
“Can they tolerate this?”
“Will this work?”
Ready to move beyond trial-and-error?
What Each Approach Actually Enables
Clinical Insight
No Testing
PGx Testing
BrightKaire
Understand metabolism
--
Assess side effect risk
--
Use genetic data
--
Guide beyond trial-and-error
--
Limited
Measure brain response
--
--
Predict likelihood a treatment will work
--
--
The Key Difference
PGx testing helps avoid what might not work. BrightKaire helps identify what is more likely to work.
Move Beyond Trial-and-Error
Start making treatment decisions based on how a patient’s brain actually responds.
Find your path
Treatment decisions guided by real brain response—not trial and error.
Patient Reality
- Many patients cycle through medications for years
- Genetic tests may explain side effects—but not whether a treatment will help
- BrightKaire reduces unnecessary suffering by pointing toward treatments more likely towork
For Providers
- Psychiatry has historically relied on proxies
- BrightKaire introduces direct biological response evidence—not guesswork